Arcutis Biotherapeutics (ARQT) Cash & Equivalents (2019 - 2023)
Arcutis Biotherapeutics (ARQT) recorded Cash & Equivalents of $107.47 million in Q3 2023, up 31.8% from $81.54 million a year earlier and up 2.2% from the prior quarter.
Powered by 
Analysis
Arcutis Biotherapeutics (ARQT) Cash & Equivalents (2019 - 2023) Analysis & Trends
At the end of FY2022, Arcutis Biotherapeutics reported Cash & Equivalents of $53.64 million, down 44.4% from FY2021.
- Annual Cash & Equivalents has a three-year compound annual growth rate of -5.4% (FY2019 to FY2022).
- Across earlier years, Cash & Equivalents came in at $96.45 million in FY2021 (+48.2%), $65.08 million in FY2020 (+2.8%) and $63.34 million in FY2019.
- The Q3 2023 figure is the highest quarterly Cash & Equivalents since Q1 2021.
- On a year-over-year basis, Cash & Equivalents has increased for three consecutive quarters, with growth averaging 9.2% over the last eight quarters.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 70.9% in Q2 2023, against a decline of 75.8% in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $105.11 million (Q2 2023), $81.41 million (Q1 2023) and $53.64 million (Q4 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Arcutis Biotherapeutics | 3.18 Bn | 2.46 Bn | 118.92 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 107.47 Mn |
| Jun 30, 2023 | 105.11 Mn |
| Mar 31, 2023 | 81.41 Mn |
| Dec 31, 2022 | 53.64 Mn |
| Sep 30, 2022 | 81.54 Mn |
| Jun 30, 2022 | 61.51 Mn |
| Mar 31, 2022 | 69.80 Mn |
| Dec 31, 2021 | 96.45 Mn |
| Sep 30, 2021 | 51.78 Mn |
| Jun 30, 2021 | 89.13 Mn |
| Mar 31, 2021 | 288.69 Mn |
| Dec 31, 2020 | 65.08 Mn |
| Sep 30, 2020 | 45.71 Mn |
| Jun 30, 2020 | 171.55 Mn |
| Mar 31, 2020 | 190.89 Mn |
| Dec 31, 2019 | 63.34 Mn |
API Access
Arcutis Biotherapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ARQT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ARQT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ARQT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();